Evolution du traitement de l'infarctus du myocarde en Suisse de 1986 a 1990: les resultats d'une etude de population. [Developments in the treatment of myocardial infarction in Switzerland 1986-1990: results of a population survey]

Détails

ID Serval
serval:BIB_A1EB4111EE5E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Evolution du traitement de l'infarctus du myocarde en Suisse de 1986 a 1990: les resultats d'une etude de population. [Developments in the treatment of myocardial infarction in Switzerland 1986-1990: results of a population survey]
Périodique
Schweizerische Medizinische Wochenschrift
Auteur⸱e⸱s
Hungerbuhler  P., Wietlisbach  V., Rickenbach  M., Vogt  P.
ISSN
0036-7672 (Print)
Statut éditorial
Publié
Date de publication
12/1992
Volume
122
Numéro
50
Pages
1919-26
Notes
English Abstract
Journal Article
Research Support, Non-U.S. Gov't --- Old month value: Dec 12
Résumé
The Swiss cantons of Vaud and Fribourg participate in the international MONICA project (MONI-toring of trends and determinants in CArdiovascular disease). Within this context, drug therapies and procedures were recorded during two separate years (1986 and 1990) for all hospitalizations of men aged 25 to 64 with the diagnosis of myocardial infarction. The medical files were reviewed to classify this diagnosis as possible or definite on the basis of the symptoms, the ECG results and the enzymatic tests. The two study populations (n = 318 in 1986 and n = 332 in 1990) are comparable with respect to age, history of ischemic heart disease and initial care. In 1990, half of the patients arrived at hospital in less than 3 hours, the median time delay being 4 hours for those first attending a general practitioner and 2 hours for those transferred directly. The frequency of treatments between 1986 and 1990 is compared only for cases with a definite diagnosis of myocardial infarction (respectively n = 217 and n = 223). The proportion of patients given thrombolytic therapy rose from 9% to 44% (p < 0.005) and from 51% to 95% (p < 0.005) for those treated with antiplatelet drugs, whereas the proportion fell from 72% to 55% (p < 0.005) for calcium blockers and from 33% to 24% (p < 0.05) for inotropic drugs. The use of anticoagulants (in 98% of patients) and of beta blockers (in 57%) remained stable across time.(ABSTRACT TRUNCATED AT 250 WORDS)
Mots-clé
Adrenergic beta-Antagonists/therapeutic use Adult Anticoagulants/therapeutic use Calcium Channel Blockers/therapeutic use Cardiovascular Agents/*therapeutic use Humans Male Middle Aged Myocardial Infarction/diagnosis/*drug therapy/rehabilitation Platelet Aggregation Inhibitors/therapeutic use Population Surveillance Stimulation, Chemical Switzerland *Thrombolytic Therapy
Pubmed
Web of science
Création de la notice
29/01/2008 9:52
Dernière modification de la notice
20/08/2019 16:07
Données d'usage